成都普瑞法科技开发有限公司欢迎您!
ISO ISO
CNAS CNAS
高新技术企业 高新技术企业
USP USP
知识产权管理体系认证证书 知识产权管理体系认证证书

文献列表

专业生产定制高含量植提产品和中药成分

您当前的位置:
期刊名:Srinagarind Medical Journal
文献编号:
文献地址: https://scholar.google.com/scholar_url?url=https://thaidj.org/index.php/smnj/article/download/11996/10153&hl=zh-CN&sa=X&d=596453813186072715&ei=IkZwYteaI5GJmwGY-qmYDQ&scisig=AAGBfm0xqVpo-567jw3cMrUBJiF5kENr6g&oi=scholaralrt&hist=P1l9U8wAAAAJ:6061410958341296950:AAGBfm1SMj-qIFykR7xxSgbekTZuDQdibA&html=&pos=0&folt=kw
发表日期:28 March 2022
Background and Objective: Obesity has been found to be associated with testicular dysfunction, resulting in decreased sperm quality, testosterone production and consequently male infertility. The aim of this study was to determine the effects of limonin on sperm count and motility and serum testosterone level in obese rats. Methods: Male Sprague-Dawley rats were divided into the following groups; the control, the obesity (Obesity), the obesity treated with limonin at dose 100 mg/kg (LM 100) groups at the last four week of the experiment. At the end of experiment, body weight and retroperitoneal fat were measured. Sperm count and motility measurement was performed. Serum testosterone and testicular MDA level were investigated. Results: Obesity significantly elevated body weight and fat accumulation while decreased the caudal epididymal sperm concentrations and percentages of sperm motility and serum testosterone compared to the control groups. (p<0.05). Treatment with limonin significantly reduced body weight and fat mass (p<0.05). An improvement of sperm concentrations and percentages of sperm motility and serum testosterone was observed in LM 100 group (p<0.01). Testicular MDA significantly increased in Obesity, while limonin treatment significantly diminished testicular MDA level (p<0.01). Conclusion: Limonin treatment potentially represents as a supplementation for the prevention of testicular dysfunction induced by obesity.
相关产品